We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$356M
AUM Growth
+$21.4M
Cap. Flow
+$13.5M
Cap. Flow %
3.78%
Top 10 Hldgs %
21.9%
Holding
167
New
14
Increased
82
Reduced
36
Closed
17

Top Buys

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$6.43M
2
SLB icon
SLB Ltd
SLB
+$3.78M
3
PETM
PETSMART INC
PETM
+$3.64M
4
TSM icon
TSMC
TSM
+$3.11M
5
TM icon
Toyota
TM
+$2.51M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.53M
2
KDP icon
Keurig Dr Pepper
KDP
+$4.88M
3
FFIV icon
F5
FFIV
+$3.47M
4
CA
CA, Inc.
CA
+$2.97M
5
MDT icon
Medtronic
MDT
+$2.03M

Sector Composition

Rank Sector Weight
1 Technology 25.97%
2 Healthcare 12.43%
3 Industrials 12.11%
4 Energy 9.92%
5 Financials 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NOV icon
51
NOV
NOV
$6.88B
$3.11M 0.87%
44,349
+4,077
+10% +$280K
HP icon
52
Helmerich & Payne
HP
$3.37B
$3.1M 0.87%
28,861
+2,565
+10% +$239K
CHRW icon
53
C.H. Robinson
CHRW
$17.3B
$3.05M 0.86%
58,219
+4,552
+8% +$248K
SNN icon
54
Smith & Nephew
SNN
$13.6B
$2.79M 0.79%
91,355
-1,458
-2% -$44.1K
TEVA icon
55
Teva Pharmaceuticals
TEVA
$41.2B
$2.65M 0.74%
50,159
+1,374
+3% +$63.5K
JNJ icon
56
Johnson & Johnson
JNJ
$617B
$2.63M 0.74%
26,804
+59
+0.2% +$5.47K
CA
57
DELISTED
CA, Inc.
CA
$2.55M 0.72%
82,225
-91,116
-53% -$2.97M
HD icon
58
Home Depot
HD
$332B
$2.53M 0.71%
31,918
+28,972
+983% +$2.3M
MXIM
59
DELISTED
Maxim Integrated Products
MXIM
$2.49M 0.7%
75,181
+2,685
+4% +$82.5K
TM icon
60
Toyota
TM
$227B
$2.45M 0.69%
+21,714
New +$2.51M
ESV
61
DELISTED
Ensco Rowan plc
ESV
$2.4M 0.67%
11,372
+1,702
+18% +$356K
GD icon
62
General Dynamics
GD
$103B
$2.21M 0.62%
20,271
-125
-0.6% -$12.9K
DLR icon
63
Digital Realty Trust
DLR
$71.5B
$2.15M 0.6%
40,539
+8,985
+28% +$468K
THG icon
64
Hanover Insurance
THG
$8.01B
$2.11M 0.59%
34,323
+362
+1% +$21.2K
MMM icon
65
3M
MMM
$90.8B
$2.09M 0.59%
18,427
-616
-3% -$68.4K
PG icon
66
Procter & Gamble
PG
$335B
$2.03M 0.57%
25,213
+2,650
+12% +$209K
DCM
67
DELISTED
NTT DOCOMO, Inc.
DCM
$1.84M 0.52%
116,797
+6,870
+6% +$111K
BRK.B icon
68
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.83M 0.52%
14,679
+268
+2% +$31.3K
CAG icon
69
Conagra Brands
CAG
$7.19B
$1.77M 0.5%
73,241
+5,838
+9% +$140K
TD icon
70
Toronto Dominion Bank
TD
$198B
$1.72M 0.48%
36,682
-400
-1% -$18K
PFE icon
71
Pfizer
PFE
$142B
$1.49M 0.42%
48,779
-85
-0.2% -$2.53K
TT icon
72
Trane Technologies
TT
$97.3B
$1.29M 0.36%
23,091
+78
+0.3% +$4.65K
USB icon
73
US Bancorp
USB
$98B
$1.25M 0.35%
29,184
– –
RTX icon
74
RTX Corp
RTX
$289B
$1.15M 0.32%
15,626
-699
-4% -$50.2K
PEP icon
75
PepsiCo
PEP
$191B
$1.02M 0.29%
12,240
+187
+2% +$15.2K
1 2
3
4 5

Similar funds

DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return

Grimes & Company's Q1 2014 Portfolio in Review

As of Q1 2014, Grimes & Company held 167 positions worth $356M, up 6.4% from $335M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Grimes & Company deployed $13.5M of net new capital in Q1 2014, opening 14 new positions and adding to 82 existing holdings. Its largest new stake was Gen Digital: 300,398 shares worth $6M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was AstraZeneca, an estimated $6.53M trimmed.

  • Grimes & Company's largest Q1 2014 buy was Gen Digital: 300,398 shares worth $6M.
  • Grimes & Company added most to SLB Ltd in Q1 2014, an estimated $3.78M increase.
  • Grimes & Company's biggest Q1 2014 reduction was AstraZeneca, cutting an estimated $6.53M.
  • Grimes & Company fully exited F5 in Q1 2014, selling an estimated $3.47M.
  • Grimes & Company's ten largest holdings make up 22% of its $356M portfolio in Q1 2014.
  • Grimes & Company opened 14 new positions and closed 17 in Q1 2014.
  • Grimes & Company's portfolio value rose 6.4% quarter-over-quarter to $356M.

Based on Grimes & Company's 13F filing for Q1 2014, filed 1 May 2014.